Company: GIFLF
Filing Date: 2025-02-26
Form Type: 6-K
Source: 0001104659-25-017501
Chunk: 12

Company: Grifols SA
Filing Date: 2025-02-26
Form: 6-K
Chunk 12
---
 22% 24% 26% 28% 30% Q1'24 Q2'24 Q3'24 Q4'24 6.8x 5.5x 5.1x 4.6x Q1'24 Q2'24 Q3'24 Q4'24 Margin Introductory Remarks Business Performance Financials Final remarks Annex 2024 Highlights | A Record Year Sequential Improvement Across the Board Note: All figures are presented on a consolidated basis (including Biotest). When specified, figures presented at currency (c c), excluding exchange rate fluctuations over the period. See Annex for reconciliations. 1 FCF definition and reconciliation to the Cash Flow Statement in slide 39 in the Annex ; 2 Leverage ratio defined as per the Credit Agreement in slide 36 in the Annex

- 14 - Q4 2024 Results Introductory Remarks Business Performance Financials Final remarks Annex Year - to - date (in million EUR) Note: All figures are presented on a consolidated basis (including Biotest), excluding exchange rate fluctuations over the pe rio d. See Annex for reconciliations. 2024 EBITDA | A Record Year Significantly Outgrowing Prior Record Year in 2023 and Increasing Convergence Between Adjusted & Reported EBITDA Quarter (in million EUR) Growth drivers • Yields improvement • Operational leverage and cost discipline 369 444 Q4’23 482 526 Q4’24 +350bps +31% +150bps +19% 20.9% 25.1% 24.4% 26.6% 1,239 1,462 FY23 1,631 1,779 FY24 +380bps +32% +250bps +22% 18.8% 22.2% 22.6% 24.7% Reported EBITDA Adjusted EBITDA • CPL reduction • Volume growth Main adjustments. From Reported to Adjusted EBITDA • Restructuring costs • T ransaction costs Refer to slide 35 in the Annex for the detail • Biotest Next Level project • Impairments Cash adjustments: Non - cash adjustments: Reported EBITDA Adjusted EBITDA

- 15 - Q4 2024 Results Introductory Remarks Business Performance Financials Final remarks Annex Note: All figures are presented on a consolidated basis (including Biotest), and at constant currency (cc), excluding exchang e r